Neratinib(Nerlynx)

Another NameHernix、LuciNera、Nerlynx、来那替尼

IndicationsIt is indicated for the treatment of early-stage and advanced-stage HER2-positive breast cancer, and can be used as a monotherapy for adjuvant treatment or in combination with capecitabine for metasta